Subscribe To

Price Alert Latest News Economic Calendar News

CLPT / ClearPoint Neuro to Announce First Quarter 2023 Results May 11, 2023

SOLANA BEACH, Calif., April 28, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it will release financial results for its 2023 first quarter on Thursday, May 11, after the market close. Read More

Demo Live Account See Partner Details

Content Topics

Clearpoint

Neuro

Announce

First

Quarter

2023

Results

Stock

CLPT

Posted: Apr 28 2023, 16:42

Author Name: GlobeNewsWire

CLPT News

By Seeking Alpha
June 5, 2023

ClearPoint Neuro: I Continue To Rate The Stock A 'Buy'

ClearPoint Neuro's progress on its four-pillar strategy continues despite a challenging operating environment, with an increasing number of partners a

By Seeking Alpha
May 11, 2023

ClearPoint Neuro, Inc. (CLPT) Q1 2023 Earnings Call Transcript

ClearPoint Neuro, Inc. (NASDAQ:CLPT ) Q1 2023 Results Conference Call May 11, 2023 4:30 PM ET Company Participants Joe Burnett - CEO Danilo D'Alessand

By GlobeNewsWire
April 28, 2023

ClearPoint Neuro to Announce First Quarter 2023 Results May 11, 2023

SOLANA BEACH, Calif., April 28, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform

By Seeking Alpha
March 1, 2023

ClearPoint Neuro, Inc. (CLPT) Q4 2022 Earnings Call Transcript

ClearPoint Neuro, Inc. (NASDAQ:CLPT ) Q4 2022 Earnings Conference Call March 1, 2023 4:30 PM ET Company Participants Joe Burnett - CEO Danilo D'Alessa

By Seeking Alpha
January 30, 2023

ClearPoint Neuro Is A 'Buy' Based On Growing Revenues And Decreasing Cash Burn

ClearPoint Neuro is a growth story and should be evaluated as such. I break down some of the growth factors that I consider most important.

By GlobeNewsWire
November 9, 2022

ClearPoint Neuro to Present at Upcoming Investor Conferences

SOLANA BEACH, Calif., Nov. 09, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform

By Seeking Alpha
November 8, 2022

ClearPoint Neuro, Inc. (CLPT) Q3 2022 Earnings Call Transcript

ClearPoint Neuro, Inc. (NASDAQ:CLPT ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Joe Burnett - CEO Danilo D'Ale

By Seeking Alpha
July 25, 2022

ClearPoint Neuro: A 'Picks And Shovels' Biotech Company

CLPT has been growing revenues steadily and has a large addressable market. It also has a very strong moat due to the nature of the FDA approval proce

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.